Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) (Q62991870)
Jump to navigation
Jump to search
scientific article published on 24 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) |
scientific article published on 24 May 2007 |
Statements
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) (English)
F De Vita
F Giuliani
N Di Martino
F Montemurro
L Manzione
S Romito
G Catalano
G Colucci
Gruppo Oncologico Italia Meridionale